Are Universal Starch Chem Allied Ltd latest results good or bad?

Feb 12 2026 07:42 PM IST
share
Share Via
Universal Starch Chem Allied Ltd's latest results show a significant sequential profit increase, with net profit rising to ₹5.24 crores, but year-on-year net sales declined by 8.47%, indicating ongoing revenue challenges despite improved operational efficiency. Overall, while profitability has recovered, the company faces persistent difficulties in sustaining sales growth.
Universal Starch Chem Allied Ltd's latest financial results for Q3 FY26 reflect a complex operational landscape. The company reported net sales of ₹117.67 crores, which represents a sequential growth of 21.13% from the previous quarter, though it reflects an 8.47% decline compared to the same quarter last year. This indicates a recovery in sales momentum on a quarter-over-quarter basis, but persistent year-on-year revenue challenges remain evident, marking the third consecutive quarter of declining sales compared to the prior year.
The net profit for the quarter reached ₹5.24 crores, showing a substantial sequential increase of 589.47%, a notable turnaround from a loss in the earlier quarter. This profit growth is attributed to significant improvements in operational efficiency and margin expansion, with the operating profit margin rising to 8.31%, up from 4.67% in the previous quarter. The company also benefited from a reduction in interest costs, which fell by 26.47%, contributing positively to profitability. Despite these positive developments in profitability, the company continues to face challenges in sustaining revenue growth. The year-on-year decline in net sales suggests ongoing difficulties in the agricultural products sector, which may impact future performance. Additionally, the company’s return on equity and return on capital employed metrics indicate moderate capital efficiency, with recent trends showing a decline in these ratios. Overall, Universal Starch Chem Allied Ltd has demonstrated a notable recovery in profitability metrics in the latest quarter, which may suggest operational resilience. However, the persistent revenue challenges and the mixed performance indicators highlight the need for careful monitoring of the company's financial health moving forward. The company saw an adjustment in its evaluation, reflecting these operational dynamics.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News